Apellis Pharmaceuticals Inc Valor de mercado
Qual é o Valor de mercado de Apellis Pharmaceuticals Inc?
O Valor de mercado de Apellis Pharmaceuticals Inc é $5.43B
Qual é a definição de Valor de mercado?
A capitalização de mercado é o valor de mercado em um ponto no tempo das ações em circulação de uma empresa de capital aberto, sendo igual ao preço da ação nesse momento multiplicado pelo número de ações em circulação.
As outstanding stock is bought and sold in public markets, capitalization could be used as an indicator of public opinion of a company's net worth and is a determining factor in some forms of stock valuation.
Market capitalization is used by the investment community in ranking the size of companies, as opposed to sales or total asset figures. It is also used in ranking the relative size of stock exchanges, being a measure of the sum of the market capitalizations of all companies listed on each stock exchange. In performing such rankings, the market capitalizations are calculated at some significant date, such as 30 June or 31 December.
The total capitalization of stock markets or economic regions may be compared with other economic indicators. The total market capitalization of all publicly traded companies in the world was US$51.2 trillion in January 2007 and rose as high as US$57.5 trillion in May 2008 before dropping below US$50 trillion in August 2008 and slightly above US$40 trillion in September 2008. In 2014 and 2015, global market capitalization was US$68 trillion and US$67 trillion, respectively.
Valor de mercado de empresas na Setor Health Care em NASDAQ em comparação com Apellis Pharmaceuticals Inc
O que Apellis Pharmaceuticals Inc faz?
apellis pharmaceuticals is an early stage biotechnology company applying immunotherapy to auto-immune diseases, with an initial emphasis on diseases of the lungs such as asthma and chronic obstructive pulmonary disease (copd), diseases of the retina such as age-related macular degeneration (amd), and rare hematological diseases such as paroxysmal nocturnal hemoglobinuria (pnh). apellis believes that targeting a key element in the immune system called the complement system can have profound disease modifying benefits. we call this approach complement immunotherapy.
Empresas com valor de mercado semelhantes a Apellis Pharmaceuticals Inc
- Bosideng International tem Valor de mercado de $5.41B
- AGNC Investment tem Valor de mercado de $5.42B
- Ionis Pharmaceuticals Inc tem Valor de mercado de $5.42B
- Novanta Inc tem Valor de mercado de $5.42B
- China Huarong Asset Management Co tem Valor de mercado de $5.42B
- Yamana Gold tem Valor de mercado de $5.43B
- Apellis Pharmaceuticals Inc tem Valor de mercado de $5.43B
- Abbott India tem Valor de mercado de $5.43B
- Jiangsu Expressway tem Valor de mercado de $5.44B
- Crocs Inc tem Valor de mercado de $5.44B
- Guardant Health Cl. A tem Valor de mercado de $5.44B
- BWX Technologies Inc tem Valor de mercado de $5.44B
- Airtel Africa Plc tem Valor de mercado de $5.44B